In our proteomic data set, we found an enrichment of proteins involved in T-cell specific activation in CD4+ T cells among the proteins differentially expressed between MS patients and HCs, which was not observed in CD8+ T cells [26], prompting us to investigate T-cell activation in CD4+ T cells. Here, CD4 is linked to myeloid sarcoma.